Onconova Therapeutics

$0.7054
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0248 (-3.49%) Today

+$0.0202 (+2.95%) As of 1:10 PM UTC after-hours

Why Robinhood?

You can buy or sell ONTX and other stocks, options, and ETFs commission-free!

About ONTX

Onconova Therapeutics, Inc. Common Stock, also called Onconova Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA. The listed name for ONTX is Onconova Therapeutics, Inc. Common Stock.

CEO

Steven M. Fruchtman

Employees

Headquarters

Newtown, Pennsylvania

Founded

1998

Market Cap

149.73M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

31.89M

High Today

$0.74

Low Today

$0.681

Open Price

$0.7303

Volume

19.65M

52 Week High

$1.56

52 Week Low

$0.1901

Collections

ONTX Earnings

-$0.82

-$0.55

-$0.27

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 23, After Hours